AstraZeneca Completes Acquisition Of Fusion Pharma

(RTTNews) - AstraZeneca (AZN.L, AZN), on Wednesday, announced the completion of the acquisition of Fusion Pharmaceuticals Inc., a clinical-stage biopharmaceutical company developing next-generation radioconjugates (RCs). https://www.nasdaq.com/articles/astrazeneca-completes-acquisition-fusion-pharma